Intrinsic4D Inc.: Investor Update Call to Be Held on Monday, June 22nd

TORONTO, ONTARIO--(Marketwired - June 18, 2015) - Intrinsic4D Inc. (TSX VENTURE:IFD) (the "Corporation") announces that the investor update call previously scheduled for Friday, June 19, 2015 at 8:30 a.m. has been cancelled and rescheduled for Monday, June 22, 2015 at 8:30 a.m. The conference call will include remarks by management and provide on update on the Corporation's progress, business strategy and objectives. This will be followed by a question-and-answer session. A presentation is available on the Corporation's website (www.intrinsic4d.com).

The Corporation expects its common shares to resume trading on the TSX Venture Exchange (the "TSXV") under the symbol "IFD" on Monday, June 22, 2015.

To participate in the conference call, dial:

Dial in: 641.715.3580

Access Code: 363-711#

Additional Disclosure

As previously announced by the Corporation on June 16, 2015, the Corporation completed its qualifying transaction (the "Transaction") pursuant to Policy 2.4 - Capital Pool Companies of the TSXV. The Transaction was completed in accordance with the merger agreement and plan of reorganization dated March 6, 2015, as amended (the "Merger Agreement"), pursuant to which Maple Subco LLC, a wholly-owned subsidiary of the Corporation, merged with Intrinsic4D LLC ("Intrinsic4D"). Pursuant to the terms of the Merger Agreement, upon the closing of the Transaction, among other things, the Corporation issued to holders of outstanding purchase warrants of Intrinsic4D an aggregate of 6,617,353 economically equivalent purchase warrants (the "Intrinsic4D Warrants") to purchase Class B restricted voting shares of the Corporation ("Class B Shares"). The Intrinsic4D Warrants contain a "cashless exercise" feature, which allows the holders to exercise such Intrinsic4D Warrants by surrendering a number of Class B Shares underlying the portion of the Intrinsic4D Warrant being exercised with a fair market value equal to the aggregate exercise price payable to the Corporation. The Intrinsic4D Warrants also contain customary anti-dilution protections for reorganizations, rights offerings and similar corporate actions.

About Intrinsic4D

The Corporation owns a patented, FDA-cleared software and service platform that translates static, 2D magnetic resonance imaging (MRI) and computed tomography (CT) data and produces a non-invasive, 360 degree, novel visualization of patient anatomy in 3D. The Corporation is monetizing the platform through an innovative and compelling service targeted at the medical and legal fields, with an additional opportunity in the cardiovascular market. The Corporation's proprietary technology is protected by four issued patents and eleven pending patent applications. In May 2012, The Corporation received 510(k) regulatory clearance from the United States Food and Drug Administration to market its product.

Disclaimer for Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws. Forward-looking information may relate to the Corporation's future outlook and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Corporation. Particularly, statements regarding future results, performance, achievements and prospects or opportunities for the Corporation are forward-looking statements. In some cases, forward-looking information can be identified by such terms such as "may", "might", "will", "could", "should", "would", "occur", "expect", "plan", "anticipate", "believe", "intend", "estimate", "predict", "potential", "continue", "likely", "schedule", or the negative thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to the expected commencement of trading of common shares of the Corporation on the TSXV.

Although the forward-looking statements contained in this press release are based upon assumptions that management of the Corporation believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Corporation's control, which may cause actual results to differ materially from those expressed or implied by such forward-looking statements.

The forward-looking statements made in this press release relate only to events or information as of the date hereof. Except as required by applicable law, the Corporation undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.